Mediar secures $85m in Series A funding to advance fibrosis therapies portfolio
Mediar Therapeutics has secured $85m in a Series A round co-led by Novartis Venture Fund and Sofinnova Partners, which brings the company’s total financing to $105m. Pfizer Ventures,